Curious, why do you think this Phase 2B is more important than the Phase 3.
I don’t think the current economy will discourage big Pharma from acquiring if trial results are stellar. They will use the downturn to buy at a smaller premium than usual. A billion dollar deal is nothing these days for big Pharma especially with the market potential of this pipeline. It’s all in the trial results and de-risking the safety and efficacy of these new drugs.